Nonetheless, our findings portend that other Ras-dependent cancers with increased abundance of SMYD3 are also likely to maintain a feedback loop driving high SMYD levels dependent on persistent activation of MAP3K2/MEK/ERK signaling. The gene discussed is MAP2K7; the disease is cancer.